ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
Why Resmed, Coles, Afterpay and one other have made early share price gains
Share Market News
Why these 7 ASX 200 shares received broker upgrades this week
⏸️ ASX Shares
The ASX healthcare shares I would buy and hold until at least 2030
Share Market News
Leading brokers name 3 ASX shares to sell today
Share Fallers
What happened to the Mesoblast Limited (ASX:MSB) share price?
Growth Shares
Got a spare $10,000 to invest? Smart investors should buy these ASX shares
⏸️ ASX Shares
10 must-buy ASX shares to snap up before it's too late
⏸️ ASX Shares
Investing $1,000 in these 3 ASX shares could be a very smart move
⏸️ ASX Shares
3 five-star ASX shares to buy next week
Share Market News
ASX 200 down 0.2%: Big four banks drop, CIMIC jumps, CSL slides lower
⏸️ ASX Shares
Is the ResMed (ASX:RMD) share price a strong buy today?
How to invest
You could become very wealthy by investing $1,000 into these ASX shares
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
